VOV.VN - The Ministry of Health confirmed no new locally-transmitted COVID-19 cases on the morning of March 1, keeping the national tally at 2,448, while the total recoveries hit 1,876 in total after a further 32 coronavirus patients were declared free from the virus one day earlier.

VOV.VN - Covivac, a COVID-19 vaccine developed by the Institute of Vaccines and Medical Biology (Ivac), will be tested in healthy volunteers in Vietnam on March 3, Ivac has announced.

VOV.VN - The national vaccination campaign against the novel coronavirus (COVID-19) may be delayed slightly due to the need to check the quality of the vaccine, according to Minister of Health Nguyen Thanh Long.

VOV.VN - Nano Covax, Vietnam’s first locally-produced COVID-19 vaccine, has elicited a host of antibodies that help to protect those injected against the B.1.1.7 variant of the SARS-CoV-2 virus which originates from the UK, according to a leading Vietnamese scientist.

VOV.VN - As many as 35 volunteers participated in the second phase of human trials for the locally-produced Nano Covax vaccine against the novel coronavirus (COVID-19) on February 26 at the Military Medical Academy in Hanoi.

VOV.VN - A leading Vietnamese diplomat to the United Nations Security Council (UNSC) raised concerns regarding the worsening humanitarian situation in Syria during a UNSC meeting on February 25.

VOV.VN - The second phase of human trials for the locally-produced Nano Covax vaccine against COVID-19 were launched on the morning of February 26, following the completion of the first phase to prove the vaccine’s safety.

VOV.VN - A number of domestic businesses have announced their plans to purchase novel coronavirus (COVID-19) vaccines for use among their employees and family members following the arrival of the first batch of the AstraZeneca vaccine.

VOV.VN - The Ministry of Health is considering importing two more COVID-19 vaccines produced by Moderna of the United States and Generium of Russia.

VOV.VN - The nation is projected to receive 150 million doses of novel coronavirus (COVID-19) vaccines from foreign and domestic sources by 2022, with seven batches being supplied by British-Swedish firm AstraZeneca, global vaccine access mechanism COVAX, and other domestic producers.